DexCom, Inc. (DXCM)
NASDAQ: DXCM · Real-Time Price · USD
68.10
-2.59 (-3.66%)
At close: Mar 6, 2026, 4:00 PM EST
68.80
+0.70 (1.02%)
After-hours: Mar 6, 2026, 7:32 PM EST
DexCom Stock Forecast
Stock Price Forecast
The 21 analysts with 12-month price forecasts for DexCom stock have an average target of 85, with a low estimate of 68 and a high estimate of 102. The average target predicts an increase of 24.82% from the current stock price of 68.10.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for DexCom stock from 21 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Sep '25 | Oct '25 | Nov '25 | Dec '25 | Jan '26 | Feb '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 8 | 11 | 11 | 11 | 11 | 10 |
| Buy | 8 | 6 | 6 | 7 | 8 | 8 |
| Hold | 3 | 3 | 4 | 3 | 2 | 2 |
| Sell | 0 | 0 | 0 | 0 | 1 | 1 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 19 | 20 | 21 | 21 | 22 | 21 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| BTIG | BTIG | Strong Buy Reiterates $85 | Strong Buy | Reiterates | $85 | +24.82% | Feb 25, 2026 |
| Truist Securities | Truist Securities | Strong Buy Reiterates $82 → $80 | Strong Buy | Reiterates | $82 → $80 | +17.47% | Feb 17, 2026 |
| Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $99 → $95 | Strong Buy | Maintains | $99 → $95 | +39.50% | Feb 13, 2026 |
| Barclays | Barclays | Sell Maintains $71 → $72 | Sell | Maintains | $71 → $72 | +5.73% | Feb 13, 2026 |
| Wells Fargo | Wells Fargo | Buy Maintains $93 → $85 | Buy | Maintains | $93 → $85 | +24.82% | Feb 13, 2026 |
Financial Forecast
Revenue This Year
5.34B
from 4.66B
Increased by 14.48%
Revenue Next Year
6.00B
from 5.34B
Increased by 12.39%
EPS This Year
2.54
from 2.09
Increased by 21.67%
EPS Next Year
3.04
from 2.54
Increased by 19.40%
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 5.6B | 6.4B | |||
| Avg | 5.3B | 6.0B | |||
| Low | 5.1B | 5.6B |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 20.7% | 20.1% | |||
| Avg | 14.5% | 12.4% | |||
| Low | 8.8% | 5.5% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 2.72 | 3.45 | |||
| Avg | 2.54 | 3.04 | |||
| Low | 2.33 | 2.68 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 30.1% | 35.9% | |||
| Avg | 21.7% | 19.4% | |||
| Low | 11.6% | 5.2% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.